Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 706 AL 720

Exploring Therapeutic Strategies: The Relationship between Metabolic Disorders and FOXO Signalling in Alzheimer's Disease

Kaur P, Khan H, Grewal AK, Dua K, Singh SK, Gupta G, Singh TG.

CNS Neurol Disord Drug Targets. 2025;24(3):196-207. doi: 10.2174/0118715273321002240919102841.

A Lipid-Raft Theory of Alzheimer's Disease

Rappoport A.

Annu Rev Biochem. 2025 Jun;94(1):387-416. doi: 10.1146/annurev-biochem-052024-115455. Epub 2024 Oct 30.

From defense to disease: IFITM3 in immunity and Alzheimer's disease

Kehs Z, Cross AC, Li YM.

Neurotherapeutics. 2025 Apr;22(3):e00482. doi: 10.1016/j.neurot.2024.e00482. Epub 2024 Nov 8.

The Amyloid Cascade Hypothesis: A Conclusion in Search of Support

Castellani RJ, Jamshidi P, Plascencia-Villa G, Perry G.

Am J Pathol. 2025 Nov;195(11):1988-1997. doi: 10.1016/j.ajpath.2024.10.014. Epub 2024 Nov 10.

Investigating interleukin-8 in Alzheimer's disease: A comprehensive review

Righi D, Manco C, Pardini M, Stufano A, Schino V, Pelagotti V, Massa F, Stefano N, Plantone D.

J Alzheimers Dis. 2025 Jan;103(1):38-55. doi: 10.1177/13872877241298973. Epub 2024 Nov 18.

The LDL Receptor-Related Protein 1: Mechanisms and roles in promoting Aβ efflux transporter in Alzheimer's disease

Li W, Chen C, Xu B, Chen J, Yang M, Gao L, Zhou J.

Biochem Pharmacol. 2025 Jan;231:116643. doi: 10.1016/j.bcp.2024.116643. Epub 2024 Nov 20.

The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer's disease

Salminen A.

J Mol Med (Berl). 2025 Jan;103(1):1-19. doi: 10.1007/s00109-024-02504-x. Epub 2024 Nov 27.

The role of kynurenine pathway metabolism mediated by exercise in the microbial-gut-brain axis in Alzheimer's disease

Wang Y, Wu W, Zeng F, Meng X, Peng M, Wang J, Chen Z, Liu W.

Exp Neurol. 2025 Feb;384:115070. doi: 10.1016/j.expneurol.2024.115070. Epub 2024 Nov 26.

Nanomedicine in the treatment of Alzheimer's disease: bypassing the blood-brain barrier with cutting-edge nanotechnology

Dong N, Ali-Khiavi P, Ghavamikia N, Pakmehr S, Sotoudegan F, Hjazi A, Gargari MK, Gargari HK, Behnamrad P, Rajabi M, Elhami A, Saffarfar H, Nourizadeh M.

Neurol Sci. 2025 Apr;46(4):1489-1507. doi: 10.1007/s10072-024-07871-4. Epub 2024 Dec 6.

Unveiling the Involvement of Herpes Simplex Virus-1 in Alzheimer's Disease: Possible Mechanisms and Therapeutic Implications

Chauhan P, Begum MY, Narapureddy BR, Gupta S, Wadhwa K, Singh G, Kumawat R, Sharma N, Ballal S, Jha SK, Abomughaid MM, B D, Ojha S, Jha NK.

Mol Neurobiol. 2025 May;62(5):5850-5874. doi: 10.1007/s12035-024-04535-4. Epub 2024 Dec 9.

Peptide-based inhibitors and nanoparticles: Emerging therapeutics for Alzheimer's disease

Mojarad-Jabali S, Roh KH.

Int J Pharm. 2025 Jan 25;669:125055. doi: 10.1016/j.ijpharm.2024.125055. Epub 2024 Dec 7.

Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease

Chib S, Dutta BJ, Chalotra R, Abubakar M, Kumar P, Singh TG, Singh R.

Phytother Res. 2025 Feb;39(2):747-775. doi: 10.1002/ptr.8406. Epub 2024 Dec 11.

The Beneficial Effects of Combined Exercise and Polyphenols in Alzheimer's Disease

Tan Q.

Phytother Res. 2025 Feb;39(2):1020-1034. doi: 10.1002/ptr.8422. Epub 2024 Dec 24.

Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies

Tripathi S, Sharma Y, Kumar D.

Curr Protein Pept Sci. 2025;26(4):259-281. doi: 10.2174/0113892037326839241014054430.

Uncovering the Healing Power of Stem Cells: Harnessing Regenerative Therapies for Alzheimer's Disease

Mehrabadi S.

Curr Aging Sci. 2025;18(3):175-184. doi: 10.2174/0118746098334856250106055739.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias